UK Medical announces ‘strategic buy out’ from BD

175

A Sheffield healthcare company has announced a strategic ‘buy out’ from its parent company, BD (Becton, Dickinson and Company), a deal which will see the company independently trade once again as UK Medical Ltd.

UK Medical supplies a range of interventional medical devices to the UK’s National Health Service (NHS) and the private healthcare sector. The company specialises in products used in minimally-invasive image-guided procedures to diagnose and treat diseases in various organs of the body.

UK Medical’s products, which include devices in breast radiology, urology, interventional radiology and cardiology, are designed to meet individual patient needs and help clinicians deliver positive clinical results, a press release from the company says.

Going forward, UK Medical will continue to serve BD as the UK distributor for the same soft tissue and bone marrow biopsy products that UK Medical was selling before the ‘buy out’.

Speaking at the announcement Ian Aaron, managing director of the company, said: “This is a great deal for both companies and we look forward to a continued and long partnership. Alongside our biopsy range we will also have an exciting range of other innovative interventional products. We want to partner with the NHS by supplying products that add value, improve patient care pathways and at the same time provide excellent value. We are very excited to be making a difference to patients and to the NHS.”

In 2012, UK Medical was purchased by CareFusion, a medical technology company, which BD acquired in 2015.  UK Medical will now run independently from its Sheffield headquarters.